Surface treatment by electric discharge machining of Ti-6Al-4V alloy for potential application in orthopaedics

Journal of the Mechanical Behavior of Biomedical Materials
Petr HarcubaMiloš Janeček

Abstract

This study investigated the properties of Ti-6Al-4V alloy after surface treatment by the electric discharge machining (EDM) process. The EDM process with high peak currents proved to induce surface macro-roughness and to cause chemical changes to the surface. Evaluations were made of the mechanical properties by means of tensile tests, and of surface roughness for different peak currents of the EDM process. The EDM process with peak current of 29 A was found to induce sufficient surface roughness, and to have a low adverse effect on tensile properties. The chemical changes were studied by scanning electron microscopy equipped with an energy dispersive X-ray analyser (EDX). The surface of the benchmark samples was obtained by plasma-spraying a titanium dioxide coating. An investigation of the biocompatibility of the surface-treated Ti-6Al-4V samples in cultures of human osteoblast-like MG 63 cells revealed that the samples modified by EDM provided better substrates for the adhesion, growth and viability of MG 63 cells than the TiO2 coated surface. Thus, EDM treatment can be considered as a promising surface modification to orthopaedic implants, in which good integration with the surrounding bone tissue is required.

References

Jul 6, 2000·Journal of Biomedical Materials Research·T J WebsterR Bizios
Sep 17, 2002·Calcified Tissue International·B D BoyanA L Boskey
Dec 17, 2002·Journal of Biomedical Materials Research. Part a·Márcio M BelotiAdalberto L Rosa
Mar 27, 2003·Brazilian Dental Journal·Adalberto Luiz Rosa, Márcio Mateus Beloti
Jun 3, 2004·Journal of Biomedical Materials Research. Part a·Rachel L PriceThomas J Webster
Dec 9, 2004·The Journal of Arthroplasty·Frederick F BuechelMichael J Pappas
Apr 6, 2005·The Journal of Arthroplasty·Ton M J S VervestJuriaan W A Koetsier
Jun 1, 2005·Journal of Biomedical Materials Research. Part a·G ZhaoB D Boyan
Nov 26, 2005·Clinical Oral Implants Research·Márcia Soares SaderRadovan Borojevic
May 5, 2006·Clinical Oral Implants Research·Ge ZhaoBarbara D Boyan
Dec 1, 2007·Journal of Materials Science. Materials in Medicine·Ruby I ChenCarl G Simon
Apr 18, 2008·Clinical Oral Implants Research·Takashi SawaseMitsuru Atsuta
May 23, 2008·Acta Biomaterialia·Feng ChaiHartmut F Hildebrand
Jul 2, 2008·Journal of Materials Science. Materials in Medicine·Jie HeWantao Chen
Jun 10, 2009·Journal of Nanoscience and Nanotechnology·Lubica GrausovaVera Lisa
Aug 18, 2009·Physiological Research·B VagaskáK Balík
Nov 22, 2011·Journal of the Mechanical Behavior of Biomedical Materials·Josef StráskýLothar Wagner
Sep 7, 2013·Nanomedicine : Nanotechnology, Biology, and Medicine·Leonardo GuastiPatrizia Ferretti

❮ Previous
Next ❯

Citations

May 28, 2014·Materials Science & Engineering. C, Materials for Biological Applications·Jana HavlikovaLucie Bacakova
Mar 5, 2013·Journal of the Mechanical Behavior of Biomedical Materials·Hamidreza FarnoushFathollah Moztarzadeh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.